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Abstract
Background: Postpartum sepsis accounts for most maternal deaths between three and seven days postpartum,
when most mothers, even those who deliver in facilities, are at home. Case fatality rates for untreated women
are very high. Newborns of ill women have substantially higher infection risk.
Methods/Design: The objectives of this study are to: (1) create, field-test and validate a tool for community health
workers to improve diagnostic accuracy of suspected puerperal sepsis; (2) measure incidence and identify associated
risk factors and; (3) describe etiologic agents responsible and antibacterial susceptibility patterns. This prospective
cohort study builds on the Aetiology of Neonatal Infection in South Asia study in three sites: Sylhet, Bangladesh and
Karachi and Matiari, Pakistan. Formative research determined local knowledge of symptoms and signs of postpartum
sepsis, and a systematic literature review was conducted to design a diagnostic tool for community health
workers to use during ten postpartum home visits. Suspected postpartum sepsis cases were referred to study
physicians for independent assessment, which permitted validation of the tool. Clinical specimens, including
urine, blood, and endometrial material, were collected for etiologic assessment and antibiotic sensitivity.
All women with puerperal sepsis were given appropriate antibiotics.
Discussion: This is the first large population-based study to expand community-based surveillance for diagnoses,
referral and treatment of newborn sepsis to include maternal postpartum sepsis. Study activities will lead to
development and validation of a diagnostic tool for use by community health workers in resource-poor countries.
Understanding the epidemiology and microbiology of postpartum sepsis will inform prevention and treatment
strategies and improve understanding of linkages between maternal and neonatal infections.
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Background
In 2013, over 30,000 maternal deaths (11 %) were attrib-
uted to postpartum sepsis, the third most frequent cause
of the approximately 290,000 maternal deaths worldwide
[1, 2]. Very nearly all these deaths occurred in low-
resource settings. The region with the greatest proportion
of maternal deaths due to sepsis was South Asia (14 %)
[3]. Postpartum sepsis is highly preventable through
interventions that are readily available and relatively low-
cost. Historical data demonstrates a pronounced fall in
maternal mortality in developed countries in the mid-20th
century; a substantial proportion of this decline was attrib-
uted to the prevention and appropriate treatment of
maternal infections and sepsis [4]. Before antibiotics and
etiologic studies, case fatality rates exceeded 20 % [5, 6].
Where appropriate antibiotic treatment is available [7],
case fatality rates as low as 2 % are attainable [8].
Sepsis morbidity rates are 20-fold higher than mortality
rates, with complications including septicemia, shock,
peritonitis, or abscess formation requiring surgery [9, 10].
Long-term consequences, especially with delayed or
incomplete treatment, include chronic pelvic inflamma-
tory disease and bilateral tubal occlusion leading to
compromised future fertility [11]. Further, there is ser-
ious risk for infections transmitted to newborns either
vertically during the antepartum period or by direct
contact during delivery [9, 10].
The incidence of postpartum (PP) sepsis varies world-
wide, with reports between 2–10 % and varies by risk fac-
tors which include location of delivery (facility vs. home),
low socioeconomic status, poor nutrition, anemia, pro-
longed labor, premature rupture of membranes, multiple
pregnancies, primiparity, being overweight and the type of
delivery (caesarean versus vaginal), more than 5 vaginal
examinations during labor, other obstetrical maneuvers,
no use of antibiotic prophylaxis, and other factors [12, 13].
The World Health Organization (WHO) used an estimate
of 5 % incidence for the Global Burden of Diseases
(GBOD) work [11].
While there are other causes of serious maternity-
related infection among postpartum women (e.g.,
mastitis), this study focused on PP sepsis caused by
endometritis due to its dominant attribution to severe
morbidity or death. The WHO defines endometritis as:
“The infection of the genital tract occurring at any time
between the onset of the rupture of membranes or
labour and the 42nd day postpartum in which fever and
one or more of the following are present: pelvic pain, ab-
normal vaginal discharge or odor, and delay in the rate
of reduction of size of the uterus” [14]. The standard
treatment for PP endometritis is a combination of
broad-spectrum intravenous antibiotics [15–17]. How-
ever, there are currently no global standard guidelines
for oral therapies in resource-poor regions—a lack that
impacts women who have limited access to adequate
healthcare facilities. Epidemiologic evidence on the tim-
ing of onset of conditions suggest that the majority of
maternal deaths occur on the day of childbirth due to
haemorrhage and hypertensive disorders [18]. However,
an estimated 13 % of maternal deaths occur between
days 3–7, with endometritis being the most frequent
cause of death during this time period [12, 19, 20]. This
is opposite the pattern for other direct causes of maternal
death including haemorrhage and pregnancy-induced
hypertension, where more than 90 % of these deaths occur
during the first 48 hours after birth [19]. More recent data
report declines in intrapartum deaths by more than 35 %,
such that more than a third (36 %) of maternal deaths
occur in the time period from 24 hours to 42 days after
delivery - more than either the antepartum (25 %),
intrapartum and immediate postpartum (<24 hours PP:
28 %), or late PP period (>42 days PP: 12 %) [2]. The
timing of PP sepsis, coupled with high rates of home
deliveries in many low-resource settings [21] has meant
that most sepsis cases and deaths occur at home [12, 20].
Until recently, strategies to prevent maternal sepsis
emphasized facility-based interventions: infection pre-
vention, early identification, and treatment. Efforts to
reduce maternal mortality due to sepsis, particularly in
South Asia, are hampered by the large proportion of
births which occur outside of the formal health sector,
where only 41 % of births in South Asia are attended by
a skilled birth attendant [21]. The most recent Demo-
graphic and Health Surveys (DHS) indicate that 37 % of
births in Bangladesh (57 % in urban areas and 31 % in
rural areas - where almost 80 % of births occur), and
48 % of births in Pakistan (68 % urban and 40 % rural-
where 70 % of births occur), respectively take place in
health facilities [22–24]. For women who do access facil-
ity services, variable quality of obstetric care and limited
duration of stay after delivery suggest that facility care
alone does not necessarily protect women from develop-
ing infections.
Evidence of the effect of community-based interven-
tions to reduce maternal sepsis mortality remains scarce
[25, 26], and is limited to interventions to prevent mater-
nal sepsis, not detect and treat it. Training traditional
birth attendants and supplying them with clean delivery
kits has been associated with reduced infection and ma-
ternal mortality in Pakistan [27], Egypt [28] and
Tanzania [29], but not in Bangladesh [30]. In Pakistan,
odds of puerperal sepsis were greatly reduced among the
trained community health workers (CHWs) (OR 0.17, 95
% CI 0.13-0.23) compared to the controls and there was
a non-significant reduction in maternal mortality (OR
0.74, 95 % CI 0.45-1.23). A recent systematic review also
found that clean delivery kits presented as part of a
package of interventions that involve training CHWs on
Bartlett et al. Reproductive Health  (2016) 13:16 Page 2 of 10
recognition and referral and educating women were also
associated with reductions in maternal sepsis [31]. A
cluster-randomized controlled trial of a participatory
intervention among women’s groups in India found in-
creases among intervention clusters in safe delivery
practices, including clean birth kit usage and hand wash-
ing among birth attendants [32]. Vaginal cleansing
(chlorhexidine or other antiseptic) does not appear to
prevent maternal or newborn infection, although a non-
significant decline in endometritis has been documented
(risk ratio 0.83; 95 % confidence interval 0.61 to 1.13)
[33]. Evidence also suggests that supplementation with
micronutrients can reduce sepsis mortality [34–36].
However, findings from recent community-based ran-
domized trials in Ghana and Bangladesh suggest that
supplementation with vitamin A does not significantly
reduce maternal mortality (either sepsis-related or all-
cause) [37, 38], nor does the WHO recommend routine
vitamin A supplementation during pregnancy [39, 40].
New postnatal care guidelines emphasize the risk follow-
ing discharge from a facility, and includes recommenda-
tions to educate women about symptoms of sepsis, and to
assess for temperature, lochia and uterine tenderness dur-
ing postnatal checks.
However, there is virtually no evidence about
community-based methods for maternal PP sepsis diag-
noses and treatment. This study seeks to address that
gap. Many of the risk factors for maternal PP sepsis are
also those that also put newborns at risk. In recent years,
advances made in the development and use of simple
clinical diagnostic algorithms and referral or treatment
through front-line health workers. These programs have
achieved reductions of 34 to 67 % in neonatal mortality
[41, 42]. This information has been taken up at national
and international program and policy levels – providing
an opportunity to reduce newborn mortality in other
low-resource settings [43]. The majority of maternal PP
sepsis deaths are almost completely avoidable through
using aseptic methods, along with timely diagnosis and
prompt treatment for those women who develop
infection.
This study, Development of a community-based pre-
sumptive clinical diagnosis algorithm and treatment
regimen for maternal puerperal sepsis in South Asia is a
supplement to the Bill and Melinda Gates Foundation
funded Aetiology of Neonatal Infection in South Asia
(ANISA) study which was established as a multi-country
research project to determine the incidence and etiology
of community-acquired neonatal infections in multiple
sites through prospective birth surveillance systems. It
builds upon previous work to detect and manage newborn
sepsis in the community [42, 44]. In this study follow up
of postpartum women by CHWs was added to the surveil-
lance system with the overall goal to detect and treat
women with PP sepsis and avert sepsis-related maternal
deaths. It was implemented in three sites: rural Sylhet,
Bangladesh, urban Karachi and rural Matiari, Pakistan
(Fig. 1). The objectives of this study are to (1) develop,
Fig. 1 Study Sites
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field test, and validate a locally-adapted algorithm for
CHWs to assess both the ability of the CHW to identify
the signs and symptoms of PP sepsis in the draft algorithm
and the effectiveness of the algorithm as a tool to identify
women with PP sepsis; (2) measure PP infection incidence
and determine risk factors to inform prevention strategies;
(3) to determine etiology and antimicrobial susceptibility
patterns to inform appropriate community-based empiric
antimicrobial regimens.
Methods/Design
Study design and procedures
The PP sepsis supplement to ANISA is a partnership
between the Johns Hopkins Bloomberg School of Public
Health of the Johns Hopkins University, the Child
Health Research Foundation and the International Cen-
ter for Diarrhoeal Disease Research, Dhaka, Bangladesh
(icddr,b), Shimantik in Sylhet, Bangladesh, and the Aga
Khan University in Karachi, Pakistan. The community-
based surveillance systems utilized by ANISA allows
CHWs to register married women of reproductive age
(13-49 years), identify pregnancies during surveillance
home visits conducted every two months, conduct birth
preparedness visits at 12–20 weeks and 28–30 weeks of
pregnancy (Fig. 2), and carry out 10 postpartum home
visits to all enrolled newborns. Details of the ANISA
study and site surveillance systems are available elsewhere
[45, 46]. The study was implemented in two phases be-
tween June 2012 and August 2014: (1) formative research
to assist in the development of an algorithm including sys-
tematic literature reviews and qualitative research; and (2)
algorithm validation and integration into the ANISA new-
born surveillance platform which included referral, clinical
confirmation, specimen collection and etiologic assess-
ment of PP sepsis episodes by comprehensive testing of
clinical samples.
In the formative phase (June to October 2012), in-depth
interviews and focus group discussions were carried out
among facility and community-based health care pro-
viders and beneficiaries to elicit local definitions and
understanding of signs and symptoms of PP sepsis. Par-
ticipant groups included facility-based health providers,
women with PP sepsis admitted to facilities, female rela-
tives of women admitted with PP sepsis, community-
based healthcare providers for women with PP sepsis
before referring them to facilities, recently delivered
women in the community, family members of recently de-
livered women in the community, and community-based
unskilled healthcare providers.
Data were transcribed, coded, and analyzed to exam-
ine: 1) local terminology corresponding to clinical signs
of PP sepsis; 2) care-seeking, sources of care, and treat-
ment given for conditions compatible with PP sepsis in
the community. Interim findings were utilized to inform
the CHW algorithm content and key issues for imple-
mentation, e.g., ensuring a private place for interviews
and training CHWs to probe sensitively for additional
maternal symptoms and signs. Detailed results are being
prepared for publication.
To complement primary data collection, two system-
atic literature reviews were conducted, implemented
jointly and led by WHO and CDC respectively to (1)
identify other potential algorithms and possible clinical
components; and (2) examine literature on both re-
ported etiology (Requejo J, Widmer M, Bartlett L, Kaur
G, Allen T, Gross P, et al. A systematic review of clinical
diagnostic algorithms on puerperal sepsis for potential
use at the community level. Unpublished) and potential
oral antibiotic regimens for women who are unable to
undergo facility-based parenteral treatment [47]. These,
plus expert consultation, led to a community-based PP
sepsis algorithm (Table 1) and supporting procedures for
referral, case management, algorithm validation, speci-
men collection and analysis.
The PP sepsis study enrolled consenting women for
maternal infection surveillance with live birth and still-
birth outcomes identified within 14 days of the birth
outcome. Maternal infection surveillance procedures
were integrated into existing ANISA postpartum home
visit schedule; on days 0, 2, 6, 13, 20, 27, 34, 41, 48 and
59 postpartum. Presumptive cases of PP sepsis were de-
fined based on measured temperature, maternal history
of fever, lower abdominal or pelvic pain, and abnormal
or foul-smelling discharge. Women with high fever
(>39.0 °C) at the time of assessment were classified as
having suspected PP sepsis and referred. Women with
either fever (38.0-39.0 °C) or history of fever paired with
at least one additional symptom of sepsis (lower abdom-
inal pain, pelvic pain, or abnormal/foul-smelling dis-
charge) are also presumptively classified as having PP
sepsis and referred (Table 1). Women with any serious
life-threatening health conditions, whether PP sepsis or
not, were also referred to tertiary care facilities.
Among suspected cases of PP sepsis, facility (Sylhet, Ka-
rachi) and/or home-based (Matiari) physician assessments
were carried out. In Sylhet and Karachi, home-based fol-
low up by physicians occurred only among individuals
who could not adhere to CHW-recommended referral.
Because of the distance between tertiary care facilities and
the remote field site in Matiari, study physicians visited
CHW-determined suspected PP sepsis cases in their
homes. In all instances, physician-confirmed cases were
asked to provide biospecimens (urine and blood in the
home; endometrial in health facilities) and were prescribed
an oral antibiotic treatment regimen. Women who con-
sented to referral and admission to hospital for treatment
were managed according to the local standard of care,
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Fig. 2 Surveillance system for postpartum maternal infection in Karachi Matiari* and Sylhet
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although adherence to the WHO recommended treatment
in the Managing Complications in Pregnancy and Child-
birth (MCPC) [48] was encouraged. In the event of death,
family members were interviewed to determine likely
cause of death under the auspices of another study in the
region with the Alliance for Maternal and Newborn
Health Improvement (AMANHI).
Sample size calculation and sampling strategy
A pregnancy cohort of 26,200 women across the three
sites over a one-year implementation period was ex-
pected, and was rounded up to 28,000 women to ac-
count for any change in population size by immigration
or birth rates resulting in more pregnancies. We deter-
mined that this sample was adequate for measuring out-
comes in all three objectives. Using a conservative
estimate of 5 % prevalence of PP sepsis among postpar-
tum women, we estimated that ~36 clinical sepsis cases
per month on average for each site would be identified;
resulting in a total of 1,310 cases per year (Table 2). This
sample size is adequate to estimate PP sepsis incidence
rate with at least 1 % margin-of-error at α = 0.05. To val-
idate the algorithm for CHWs and its application, study
physicians, blinded to the CHW clinical diagnoses,
assessed a random sample of suspected PP sepsis (n =
75) and healthy women (n = 225) to meet the required
sample size for assessing sensitivity of 95 % and specifi-
city of 97.5 % with 5 % and 2.5 % margins of errors, re-
spectively, and 5 % Type-I (α) error. Verification bias
due to oversampling of control women will be corrected
with statistical methods during analysis [49, 50]. The
study physicians’ diagnostic decision-making was the
gold standard and was standardized using training mate-
rials about PP sepsis based on WHO Manual of Compli-
cations in Pregnancy and Childbirth diagnostic criteria
(fever, chills, lower abdominal pain, purulent, foul-
smelling lochia, tender uterus, +/- light vaginal bleeding
and signs and symptoms of shock). When possible, phys-
ician validation was performed in health facilities.
To determine the etiology and antibiotic resistance pat-
tern of PP sepsis bacterial isolates at the three study sites,
we anticipated identifying and obtaining consent from 70 %
of the estimated 1,310 women with PP sepsis in the birth
cohort across the three sites (Table 2). This will allow for
robust data on etiology, etiology specific incidence of PP
sepsis, and will provide specific antibiotic susceptibility data
for detected pathogens. In all instances of physician-
confirmed PP sepsis, consent was sought from women who
adhered to referral for urine, blood, endometrial and high
vaginal swab (HVS) samples (HVS only done in Pakistan).
Informed consent was obtained from women with phys-
ician-confirmed sepsis with the option for them to con-
sent to provide one, two, all, or none of the specimens
(urine, blood and endometrial sample) requested. Endo-
metrial specimens were only collected in hospitals by
physicians who received clinical training on the Tao
Brush by Cook Medical before use [51].
Surveillance continued until 150 women in each site
consented to all three specimens. Among women who
declined referral and received a home-based assessment
by a study physician, consent was obtained only for
home-based collection of urine and blood.
Table 1 Simplified algorithm for identifying postpartum maternal infection
Symptoms screened by CHWs Classification
High fever [temperature 102.4 °F (39.1 °C) or higher] Suspected PP sepsis
Fever [temperature 100.6 °F - 102.3 °F (38.1 °C – 39.0 °C)] Suspected PP sepsis if fever present at examination or history of fever AND
any other sign or symptom listed is present
History of fever
Lower abdominal or pelvic pain
Abnormal or foul-smelling discharge
Severe Vaginal bleeding Other suspected illness
Severe headache AND blurred vision
Leaking urine and/or stool
Convulsions or unconscious
Lower abdominal pain (without fever)
Fever only [temperature 100.6 °F - 102.3 °F (38.1 °C – 39.0 °C)] Suspected Local Infection
History of fever only
Abnormal or foul-smelling vaginal discharge (without fever)
Burning upon micturition
Cough or difficulty breathing
Pus or pain from tear, c- section or episiotomy wound
Swollen, red, or painful breast
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Laboratory methods
Laboratory testing used standardized cross-site protocols
[52]. Site-specific analyses yielded a revised list of patho-
gens (Table 3) and their relative proportions among
women with suspected PP sepsis were compared. A list of
recommended antibiotic therapies were postulated after
evaluating the results of susceptibility testing. Further de-
tails on laboratory methods, diagnostic testing, and quality
assurance procedures used in this study are described in
Shakoor et al.’s Diagnostic methods to determine micro-
biology of postpartum endometritis in South Asia: labora-
tory methods protocol used in the Postpartum Sepsis
Study, a prospective cohort study, also published in this
journal issue [53].
Analysis plan
The diagnostic performance of the algorithm applied by
CHWs in a field setting depends upon the effectiveness of
the algorithm as a tool to identify women with PP sepsis
and the ability of the CHWs to identify the signs and symp-
toms of PP sepsis described in the algorithm. Validity mea-
sures will be calculated using the gold standard physician
assessment. Sensitivity and specificity with 95 % confidence
intervals (CI) will be calculated at two levels: identification
of individual signs and symptoms and classification of sus-
pected PP sepsis. Agreement between CHW and physician
assessments will be evaluated using the Kappa statistic.
Change in inter-rater agreement over time will also be cal-
culated to assess any improvement in the ability of the
CHWs to accurately clinically diagnose patients.
Population-level incidence of PP sepsis will be calcu-
lated based on both CHW and physician determination
of whether women have suspected PP sepsis. Misclassifi-
cation of diagnosis (false positive, false negative) could
bias the estimate. This concern will be alleviated by
using sensitivity and specificity estimates from the
validation results and correct incidence estimates for
unbiased results. Multivariate regression will be used
to identify risk factor data on demographic, socioeco-
nomic, health status and care-seeking characteristics
of pregnant women in the study collected at the time
of enrollment and during CHW scheduled prenatal
home visits.
Ethical considerations
Ethics, consent and permissions: A full review for human
subject research was conducted by the Institutional Review
Board at Johns Hopkins University, by the Ethical Review
Committees at the International Center for Diarrhoeal
Disease Research, Dhaka, Bangladesh, the Aga Khan
University in Pakistan, and the Bangladesh Institute for
Child Health for the Child Health Research Foundation in
Bangladesh. Informed oral consent was taken at each level
as described in detail.
Discussion
CHWs and mothers expressed their approval that the
mothers were also included in the birth surveillance out-
comes research in a systematic way. Due to their familiarity
Table 2 Study population and expected sepsis cases
Characteristics Sylhet Matiari Karachi Total
Population ~340000 ~340000 ~270000 950000
Yearly birth cohort 10200 8500 7500 26200
Conservative estimate of PP sepsis cases (5 % prevalence) 510 425 375 1310
Table 3 List of suspected pathogens
Facultative aerobic bacterial pathogens Anaerobic bacteria Atypical bacteria by Real time PCR
(a) Gram-positive Peptococcus sp. Chlamydia trachomatis
Beta-hemolytic streptococci—Groups A, B, C, D, F Peptostreptococcus sp. Mycoplasma hominis, genitalium
Other streptococci (intermedius, sanguis, etc) Bacteroides fragilis, bivis, disiens Uroplasma urealyticum
Enterococci Clostridia ramosum,




Enterobacteriaceae, such as klebsiella pneumoniae, enterobacter, escherichia
coli, citrobacter, proteus mirabilis
Pseudomonas aeruginosa
Neisseria gonorrheae
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with the newborn sepsis algorithm, the CHWs were readily
able to understand, adopt and implement the maternal PP
sepsis diagnostic and referral algorithm. Because of the in-
timate nature of an endometrial sample, the consent form
was designed so that women could choose to consent to
any, all or none of the specimens in order to provide a set-
ting where women may feel comfortable providing less in-
vasive blood and urine, but able to opt out of the
endometrial sample. This did not interfere with attaining
the sample size of linked specimens.
For women with suspected PP sepsis who could not
comply with referral or facility-based treatment, physi-
cians went to their homes to perform the clinical assess-
ment and encourage facility admission for treatment.
For those who could not comply, oral antibiotic treat-
ment was prescribed– the regimen was based on the
three oral/parenteral antibiotic regimens identified in
the literature review, and differed depending on avail-
ability and cost in each site [47]. Although there is no
global standard for oral treatment, we reasoned that
even if considered sub-optimal to parenteral treatment,
oral treatment would be more beneficial to women with
suspected sepsis than offering no treatment. While our
study focused on diagnoses of PP sepsis, women with
health complaints for themselves or their newborns were
also referred to the nearest facility, with facilitation by
the CHWs when necessary.
The study implementation encountered several oper-
ational challenges in the beginning that were successfully
addressed those with concerted team efforts. In Sylhet
site, recruitment of female physicians at the rural sub-
district hospitals was a great challenge for the team.
Local cultural practices prohibited the use of male physi-
cians in examining postpartum women for PP sepsis and
for collection of the endometrial specimens. In collabor-
ation with local community leaders and key stakeholders
in Sylhet, two female physicians were recruited and
employed by the study. Training and standardization of
physicians and CHWs was also a challenge. However, in
collaboration with the Gynecology Department of the
Sylhet Osmani Medical College (the only teaching
hospital in the area), study physicians and CHWs were
successfully trained to conduct clinical examinations for
PP sepsis.
In all three sites, physicians received additional training
to collect endometrial specimens in tertiary facilities
under direct supervision of obstetric consultants. Once
collected, laboratory analyses were carried out in Sylhet,
Bangladesh and Karachi, Pakistan. In the former, anaer-
obic culture of specimens was a challenge, mitigated in
part by the training of senior laboratory staff at Johns
Hopkins Hospital in Baltimore, MD USA.
This study will provide an efficient diagnostic tool for
community health workers to identify women with
suspected sepsis for referral and management in
addition to a critical evidence base for understanding
the epidemiology and etiology of PP sepsis among
women in Bangladesh and Pakistan. Although evidence
exists on the feasibility, acceptability and effectiveness
of community-based approaches for identification and
management of newborn infections through CHWs, this
is the first study of its kind to place equal emphasis on
maternal puerperal infections and explore options for
integration of the two in community settings. New data
generated on the epidemiology of PP sepsis at the com-
munity level in three South Asian sites may inform fu-
ture public health action to prevent or manage this life-
threatening illness. If effective, this diagnostic tool can
be applied throughout South Asia and other settings
where community-based postnatal care could be imple-
mented - contributing to prevention of maternal mor-
tality from PP sepsis.
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